Switch theme
Sign up to access all valuation multiples
MedAdvisor Ltd is engaged in the development and deployment of the MedAdvisor medication and adherence platform. The MedAdvisor platform is focused on improving health outcomes by connecting health professionals with their patients using mobile and web technologies. It has three reporting segments: ANZ Operations, U.S. Operations and UK Operations. The company derives majority of its revenues from U.S. Operations.
2010
n/a
LTM Revenue $69.5M
LTM EBITDA $2.1M
$46.0M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
MedAdvisor has a last 12-month revenue of $69.5M and a last 12-month EBITDA of $2.1M.
In the most recent fiscal year, MedAdvisor achieved revenue of $77.2M and an EBITDA of $4.5M.
MedAdvisor expects next 12-month revenue of XXX and NTM EBITDA of XXX
See MedAdvisor valuation multiples based on analyst estimates| FY 2023 | FY 2024 | FY 2025 | LTM | NTM | |
|---|---|---|---|---|---|
| Revenue | $62.0M | $77.2M | XXX | XXX | XXX |
| Gross Profit | $22.1M | $37.6M | XXX | XXX | XXX |
| Gross Margin | 36% | 49% | XXX | XXX | XXX |
| EBITDA | -$1.9M | $4.5M | XXX | XXX | XXX |
| EBITDA Margin | -3% | 6% | XXX | XXX | XXX |
| Net Profit | -$11.0M | -$7.1M | XXX | XXX | XXX |
| Net Margin | -18% | -9% | XXX | XXX | XXX |
| Net Debt | $2.2M | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of March 14, 2025, MedAdvisor's stock price is AUD 0 (or $0).
MedAdvisor has current market cap of AUD 66.2M (or $41.9M), and EV of AUD 72.7M (or $46.0M).
See MedAdvisor trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $46.0M | $41.9M | XXX | XXX | XXX | XXX | $-0.00 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Sign UpAs of March 14, 2025, MedAdvisor has market cap of $41.9M and EV of $46.0M.
MedAdvisor's trades at 0.7x LTM EV/Revenue multiple, and 21.8x LTM EBITDA.
Analysts estimate MedAdvisor's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for MedAdvisor and 10K+ public comps| FY 2024 | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|
| EV | $46.0M | XXX | XXX | XXX |
| EV/Revenue | 0.6x | XXX | XXX | XXX |
| EV/EBITDA | 16.3x | XXX | XXX | XXX |
| P/E | -35.7x | XXX | XXX | XXX |
| P/E/Growth | n/a | XXX | XXX | XXX |
| EV/FCF | -29.7x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Sign UpMedAdvisor's NTM/LTM revenue growth is 4%
MedAdvisor's revenue per employee for the last fiscal year averaged n/a, while opex per employee averaged n/a for the same period.
Over next 12 months, MedAdvisor's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate MedAdvisor's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for MedAdvisor and other 10K+ public comps| FY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|---|
| Revenue Growth | 25% | XXX | XXX | XXX | XXX |
| EBITDA Margin | 4% | XXX | XXX | XXX | XXX |
| EBITDA Growth | -333% | XXX | XXX | XXX | XXX |
| Rule of 40 (SaaS-only) | 8% | XXX | XXX | XXX | XXX |
| Revenue per Employee | n/a | XXX | XXX | XXX | XXX |
| Opex per Employee | n/a | XXX | XXX | XXX | XXX |
| S&M Expenses to Revenue | 2% | XXX | XXX | XXX | XXX |
| G&A Expenses to Revenue | 38% | XXX | XXX | XXX | XXX |
| R&D Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
| Opex to Revenue | 59% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Benevolent AI | XXX | XXX | XXX | XXX | XXX | XXX |
| Alcidion Group | XXX | XXX | XXX | XXX | XXX | XXX |
| CurveBeam AI | XXX | XXX | XXX | XXX | XXX | XXX |
| Doctor Care Anywhere | XXX | XXX | XXX | XXX | XXX | XXX |
| Echo IQ | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
MedAdvisor acquired XXX companies to date.
Last acquisition by MedAdvisor was XXXXXXXX, XXXXX XXXXX XXXXXX . MedAdvisor acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Sign Up| When was MedAdvisor founded? | MedAdvisor was founded in 2010. |
| Where is MedAdvisor headquartered? | MedAdvisor is headquartered in Australia. |
| Is MedAdvisor publicy listed? | Yes, MedAdvisor is a public company listed on ASX. |
| What is the stock symbol of MedAdvisor? | MedAdvisor trades under MDR ticker. |
| When did MedAdvisor go public? | MedAdvisor went public in 2011. |
| Who are competitors of MedAdvisor? | Similar companies to MedAdvisor include e.g. Benevolent AI, Alcidion Group, CurveBeam AI, Doctor Care Anywhere. |
| What is the current market cap of MedAdvisor? | MedAdvisor's current market cap is $41.9M |
| What is the current revenue of MedAdvisor? | MedAdvisor's last 12-month revenue is $69.5M. |
| What is the current EBITDA of MedAdvisor? | MedAdvisor's last 12-month EBITDA is $2.1M. |
| What is the current EV/Revenue multiple of MedAdvisor? | Current revenue multiple of MedAdvisor is 0.7x. |
| What is the current EV/EBITDA multiple of MedAdvisor? | Current EBITDA multiple of MedAdvisor is 21.8x. |
| What is the current revenue growth of MedAdvisor? | MedAdvisor revenue growth between 2023 and 2024 was 25%. |
| Is MedAdvisor profitable? | Yes, MedAdvisor is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
